Recent News

Analysis of 70 Mesothelioma Cases

May 23, 2025

Malignant pleural mesothelioma is a severe cancer mainly caused by asbestos exposure. It often appears decades after exposure. Early on, symptoms can be unclear, making it difficult to diagnose. Even[…]

Read More

PORT-7 for the Treatment of Mesothelioma

May 16, 2025

Results from a clinical trial being performed on malignant pleural mesothelioma patients will be presented at the American Association for Cancer Research meeting being held in Chicago, Illinois. Results will[…]

Read More

Ageing and Mesothelioma

May 9, 2025

Mesothelioma, a rare and aggressive cancer mainly caused by asbestos exposure, mostly affects the lining of the lungs, but can also affect the lining of the abdomen, heart, and testicles.[…]

Read More

Immunotherapy to Treat Pleural Mesothelioma

April 25, 2025

Malignant pleural mesothelioma is a rare and very aggressive cancer with a poor outlook. One cancer treatment has brought hope though. The treatment is known as immune checkpoint inhibitors. There[…]

Read More

Johnson & Johnson’s Talc Settlement Proposal Denied

April 18, 2025

A United States Bankruptcy Judge from the Southern District of Texas has denied Johnson & Johnson’s $10 billion baby powder settlement proposal. This is the third time J&J has tried[…]

Read More

Asbestos Delays Wildfire Cleanup

April 11, 2025

Asbestos testing with certified asbestos consultants and other experts has been ongoing since two wildfires, Eaton and Palisades, blazed across California in 2025. More properties that were burned in the[…]

Read More

CAR-T Cell Therapy for Mesothelioma

April 4, 2025

Mesothelioma is a rare and aggressive cancer mainly caused by asbestos exposure. With the disease being rare, there are limited treatment options for the disease. This is especially true for[…]

Read More

Asbestos Tailings Could be Used to Help the Environment

March 28, 2025

An abandoned asbestos mine in Baie Verte, in Newfoundland, is expected to have a significant environmental remediation project. BAIE Minerals, a company that specializes in mineral upcycling, plans to transform[…]

Read More

Anti-Mesothelin TNaive/​SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

March 21, 2025

Primary Outcome Measures Establish the recommended phase 2 dose (RP2D) of TNhYP218 CAR T cells based on dose-limiting toxicity (DLT) of defined adverse events (AEs). Determine the preliminary objective response[…]

Read More

Surgeries for Mesothelioma

March 21, 2025

Pleural mesothelioma is a very rare and aggressive cancer mainly caused by asbestos exposure. The survival time is very low, with people typically surviving around 9 to 20 months after[…]

Read More